4 results match your criteria: "Xi'an Medical UniversityXi'an[Affiliation]"
Am J Transl Res
October 2017
Department of Cardiology, The First Affiliated Hospital of Xi'an Medical UniversityXi'an, Shaanxi Province, China.
Abnormal proliferation of vascular smooth muscle cells (VSMCs) contributes to the development of cardiovascular diseases. Studies have showed the great impact of microRNAs (miRNAs) on the cell proliferation in VSMCs. This study examined the functional roles of miR-665 in the VSMCs and explored the underlying molecular mechanisms.
View Article and Find Full Text PDFFront Pharmacol
August 2017
Department of Neurology, The First Affiliated Hospital of Xi'an Medical UniversityXi'an, China.
Retinitis pigmentosa (RP) comprises a heterogeneous group of inherited retinal diseases leading to blindness. The present study explored the protective effects of hydrogen rich saline (HRS) against the photoreceptor degeneration in the -Methyl--nitrosourea (MNU) administrated rat, a pharmacologically induced RP model. The therapeutic effects of intraperitoneal (IP) and intravitreous (IV) injections of HRS on regional retina was quantified via topographic measurements.
View Article and Find Full Text PDFFront Aging Neurosci
June 2017
Institute of Basic and Translational Medicine, and School of Basic Medical Sciences, and Shaanxi Key Laboratory of Brain Disorders, Xi'an Medical UniversityXi'an, China.
Paired immunoglobulin-like receptor B (PirB), a functional receptor for myelin-associated inhibitory proteins, plays an important role in axon regeneration in injured brains. However, its role in normal brain function with age has not been previously investigated. Therefore in this study, we examined the expression level of PirB in the cerebral cortex, hippocampus and cerebellum of mice at 1 month, 3 months and 18 months of age.
View Article and Find Full Text PDFFront Pharmacol
June 2017
Institute of Basic and Translational Medicine, Xi'an Medical UniversityXi'an, China.
Numerous studies have noted that populations treated with statins have increased risk for new-onset diabetes mellitus; however, the underlying molecular mechanisms are not fully understood. Interestingly, familial hypercholesterolemia (FH) patients with mutations in the low-density lipoprotein receptor (LDLR) gene are protected against diabetes mellitus (DM), despite these patients being subjected to long-term statin therapy. Since the common pathway between FH and statin therapy is LDLR-mediated cellular cholesterol uptake, the arising question is whether the LDLR plays an important role in the diabetogenic effect of statins.
View Article and Find Full Text PDF